Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
The media may be tired of reporting on Covid but it is still very much a problem.
624 deaths in week to 23rd March in England and Wales with Covid on death certificate, main cause in over 2/3 of those.
Excess mortality at 13% above 5year pre-pandemic average.
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/weekending24march2023
Atanasof
https://highviewpower.com/news_announcement/uk-energy-security-undermined-by-lack-of-energy-storage-capabilities/
We already have an abundance of energy at times. As renewables ramped up this will increase exponentially……
Hydrogen has a big future though we may still be 2 years from hydrogen electrolysis companies break even. Sales ramp up generally is ahead of the most optimistic projections from 3 years ago and the big hike on SPs of hydrogen companies.
The big question is whether or not an individual company can deliver. If Ceres inks the deal with Bosch and Weichai there is a clear route to profitability. Not so sure though if for political reasons that falls through.
Both comments from Titania very relevant. Pulmonary embolism is a major complication of Covid and the increased risk persists for longer than initially thought- 6 months.
Respiratory distress is also very relevant. I’m not 100% sure but if this is adult respiratory distress syndrome (ARDS) it is perhaps the most feared consequence of severe viral respiratory infections and for which there are no effective treatments, as far as I’m aware. Even mechanical ventilation is very difficult in ARDS. ARDS is probably the main infection related problem that ECMO is used for. For the non-médical amongst us ECMO is extra corporeal membrane oxygenation and there are only a small handful of centres on the UK. At the time many of us invested there was real fear that ECMO would be needed to treat severe Covid and that uk resources would be dwarfed.
Thanks Titania for posting this.
Don’t want to be pessimistic but the plan here is for offshore production of hydrogen. As far as I am aware plug and lhyfe are ahead in that niche with floating offshore electrolyser already trialled. Would love to be proven wrong though. ITM will come good though. Once supply side sorted and 10MW electrolyser scaled up in manufacture orders will come.?
https://techcrunch.com/2023/03/15/uk-spring-budget-government-trumpets-improved-tax-relief-scheme-for-rd-intensive-smes/amp/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAJaVCagdzqORgiHtQI-_4lM5XNS4SFLhBKSPN4HdHiVcQWuzWZEqXmCgUiuQRj_OMcczLxaimnK2YY5yQLR5Nk0ptxgI9Cc8QYfAE30PJSl6TPnrm0lUz3kRXKE1F06C5mF67p1DTuxZejFH4LmKY8D1IfE9mYX5lxMbqRULeswu
It looks as if ceres power should qualify for the R&D tax credit announced yesterday. Could make a big difference in cash flow over next 3 years.
https://www.lse.co.uk/rns/CWR/green-hydrogen-collaboration-with-bosch-and-linde-vgmf2fx7myqy1o0.html
Linde, like shell, exploring all the options.
https://www.upstreamonline.com/focus/china-taps-danish-technology-for-green-ammonia-project/2-1-1406429
Not ceres but a big vote of confidence in SOEC. Bosch and Weichai should get their skates on. The market won’t wait while they procrastinate!
https://www.kqed.org/news/11942172/should-everyone-be-trying-to-get-paxlovid-for-covid-now-yes-basically
Resistance can only be a matter of time.
https://www.nature.com/articles/d41586-023-00347-z
This is absolutely not a surprise.
Not certain if it qualifies as significant « complexity « but in the multi drug platform trials eg STRIVE synairgen would be the only drug that required inhaled placebo for double blindness. Other oral agents have the potential to share placebo arms.
Apologies posted by accident while still writing. Not much interest currently in op trials though this could change
Second interesting possibility would be joint venture.!That appears to be less likely but nobody will know until after the event.
I suspect we won’t see the heady heights of pre-sprinter SP for a long time. God forbid but a turn for the worse with a new more pathogenic Covid variant or bird flu transmission human to human could change the dynamic substantially.
Near term hoping for one of two things
-getting on a p3 platform trial. Most here are hoping for an inpatient trial. I think a op trial in very high risk patients would play to our strengths but there isn’t much dynamism in that group
https://oilprice.com/Alternative-Energy/Nuclear-Power/The-Future-Is-Bright-For-Pink-Hydrogen.amp.html
EDF doing some calculations on pink hydrogen. Ceres could be right technology, right time.
Any ideas why ORIT SP is trading so low? 7% below a very conservative NAV? Green coat Uk wind SP is back to pre-Truss/Kwarteng levels and pretty much on NAV. It has a very similar structure but with a less diversified portfolio.
https://www.euractiv.com/section/energy-environment/news/eu-parliament-backs-pro-nuclear-definition-for-low-carbon-hydrogen/
Pink hydrogen being treated the same as green hydrogen by EU in definition of low carbon hydrogen. Grey hydrogen excluded. Good news for ceres whose SOEC technology is ideal for pink (nuclear derived electricity). Possibly some momentum for SP? Big positive would be confirmation of deals with Bosch and Weichai on favourable terms. That’s the plan -fingers crossed ??
https://www.reuters.com/business/sustainable-business/linde-invest-18-bln-supply-clean-hydrogen-ocis-texas-plant-2023-02-06/
Not such good news for ITM. The big bucks at linde are going blue, rather than green. I’m completely against blue hydrogen; a global warming time bomb.
https://www.euractiv.com/section/energy-environment/news/nine-eu-members-want-low-carbon-hydrogen-included-in-blocs-renewables-goals/
If pink hydrogen gets the EU thumbs up this is a potential big boost for Ceres power. The SOEC high temperature electrolysis should be the natural first choice technology. Only 2 players in the SOEC game as far as I’m aware- Ceres and Bloom. If approved potentially huge in scale. France in particular have this as core direction of energy policy.